![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2017
Anzahl der Publikationen: 1
2017
Kauffmann-Guerrero, Diego 
ORCID: https://orcid.org/0000-0003-1471-3290; Kahnert, Kathrin ORCID: https://orcid.org/0000-0001-9633-3368; Reu, S.; Jung, A.; Synyaeva, Z.; Mertsch, P. und Huber, R. M.
(2017):
NSCLC patients harbouring a rare or complex EGFR mutation are more often smokers and might not benefit from first line TKI therapy.
In: Annals of Oncology, Bd. 28
ORCID: https://orcid.org/0000-0003-1471-3290; Kahnert, Kathrin ORCID: https://orcid.org/0000-0001-9633-3368; Reu, S.; Jung, A.; Synyaeva, Z.; Mertsch, P. und Huber, R. M.
(2017):
NSCLC patients harbouring a rare or complex EGFR mutation are more often smokers and might not benefit from first line TKI therapy.
In: Annals of Oncology, Bd. 28